Condition
Fractures, Ununited
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Completed1
Terminated1
Unknown1
Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04299022Recruiting
Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care
NCT02383160Not ApplicableUnknown
Scaphoid Non-union and Low-intensity Pulsed Ultrasound Trial
NCT01750840Terminated
A Clinical Registry to Collect Patient Outcome Date for the BIOMET® Stimulator Systems
NCT00916981Phase 1Completed
Treatment of Atrophic Nonunion by Preosteoblast Cells
Showing all 4 trials